Viridian Therapeutics, Inc.

NASDAQ:VRDN

Biotechnology

Healthcare
$31.44 -0.88%

-$0.15 today

Market cap
$3.57B
Beta
0.90
P/E (TTM)
-4.7
EPS (TTM)
-$3.53
52W Low $13.18High $34.29

Volume 4.02M

Average 2.86M

Balance Sheet

Inspect the capital base behind the business.

Assets

$899.42M

FY 2025 · Annual

+21.1% YoY

Liabilities

$177.25M

FY 2025 · Annual

+150.5% YoY

Equity

$722.17M

FY 2025 · Annual

+7.5% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents42.3M155.58M102.83M99.59M212.38M
Short-term Investments154.67M268.97M374.54M617.99M662.27M
Net Receivables451K102K102K00
Inventory0(6.62M)000
Other Current Assets100K6.52M9.01M20.88M19.58M
Total Current Assets200.16M424.55M486.48M738.46M894.23M
Property, Plant & Equipment (Net)2.06M2.94M3.34M3.44M3.65M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets1.49M7.61M604K501K1.54M
Total Non-current Assets3.55M10.54M3.95M3.94M5.19M
Total Assets203.71M435.09M490.42M742.4M899.42M
Account Payables2.33M14.23M2.24M2.14M8.68M
Short-term Debt00000
Tax Payables00000
Deferred Revenue289K288K288K288K367K
Other Current Liabilities3.75M4.87M12.75M10.74M19.66M
Total Current Liabilities13.64M33.35M26.64M47.87M70.7M
Long-term Debt04.65M20.21M20.58M49.94M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)1.15M861K573K284K34.24M
Other Non-current Liabilities688K1.17M989K2.02M22.37M
Total Non-current Liabilities2.36M6.68M21.77M22.89M106.56M
Total Liabilities15.99M40.03M48.4M70.76M177.25M
Common Stock239K414K540K810K1.02M
Retained Earnings(358.3M)(488.17M)(725.91M)(995.86M)(1.34B)
Accumulated OCI(157K)(390K)338K(10K)447K
Other Stockholders Equity00000
Minority Interest00000
Total Equity187.72M395.06M442.02M671.64M722.17M
Total Debt1.04M5.26M21.05M21.1M50.69M
Net Debt(41.26M)(150.32M)(81.78M)(78.5M)(161.69M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$165.0M
Short-term Investments$816.5M
Receivables$75.0M
Other Current$24.7M
Total Current Assets$1.1B
PP&E (Net)$4.8M
Intangible Assets$10.0M
Other Non-current$1.1M
Total Non-current Assets$16.0M
Total Assets$1.1B

Analysis

Selected assets total $1.1B for Latest. The largest visible component is Short-term Investments at $816.5M, about 74.4% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13GSC 13G filingNov 10, 2026
8-KCurrent reportNov 9, 2026
8-KCurrent reportNov 4, 2026
10-QQuarterly reportNov 4, 2026
4Statement of changes in beneficial ownershipAug 20, 2026

How much cash does VRDN have?

Viridian Therapeutics, Inc. (VRDN) reported $212.38M in cash and equivalents in fiscal 2025.

How much debt does VRDN carry?

Viridian Therapeutics, Inc. (VRDN) reported $50.69M of total debt, with net debt of -$161.69M.